Bone mineral density in patients with hepatic glycogen storage diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/232609 |
Resumo: | The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9–20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, n = 18), procollagen type 1 N-terminal propeptide (P1NP, n = 19), collagen type 1 C-terminal telopeptide (CTX, n = 18) and 25-OH Vitamin D (n = 23) were also measured. The participants completed a 3-day food diary (n = 20). Low BMD was defined as a Z-score ≤ −2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ −2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential. |
id |
UFRGS-2_f9eed0fe6825fff05ef81361afb76d2f |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/232609 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Jacoby, Jesica TamaraSantos, Bruna Bento dosNalin, TatiéleColonetti, KarinaRefosco, Lilia FarretSouza, Carolina Fischinger Moura deSpritzer, Poli MaraPoloni, SoraiaMendes, Roberta HackSchwartz, Ida Vanessa Doederlein2021-12-07T04:31:02Z20212072-6643http://hdl.handle.net/10183/232609001134120The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9–20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, n = 18), procollagen type 1 N-terminal propeptide (P1NP, n = 19), collagen type 1 C-terminal telopeptide (CTX, n = 18) and 25-OH Vitamin D (n = 23) were also measured. The participants completed a 3-day food diary (n = 20). Low BMD was defined as a Z-score ≤ −2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ −2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential.application/pdfengNutrients. Basel. Vol. 13, no. 9 (Sept. 2021), 2987, 11 p.Densidade ósseaDoença de depósito de glicogênioOsteocalcinaGlycogen storage diseaseBone mineral densityGSDBoneOsteocalcinPhoton absorptiometryBone mineral density in patients with hepatic glycogen storage diseasesEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001134120.pdf.txt001134120.pdf.txtExtracted Texttext/plain45421http://www.lume.ufrgs.br/bitstream/10183/232609/2/001134120.pdf.txt8e66b50a82eea290aa33a3b7ddbeb464MD52ORIGINAL001134120.pdfTexto completo (inglês)application/pdf716642http://www.lume.ufrgs.br/bitstream/10183/232609/1/001134120.pdf2fde56dd495550fbb1bcb7f2b43677b6MD5110183/2326092021-12-09 05:34:17.62353oai:www.lume.ufrgs.br:10183/232609Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-12-09T07:34:17Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Bone mineral density in patients with hepatic glycogen storage diseases |
title |
Bone mineral density in patients with hepatic glycogen storage diseases |
spellingShingle |
Bone mineral density in patients with hepatic glycogen storage diseases Jacoby, Jesica Tamara Densidade óssea Doença de depósito de glicogênio Osteocalcina Glycogen storage disease Bone mineral density GSD Bone Osteocalcin Photon absorptiometry |
title_short |
Bone mineral density in patients with hepatic glycogen storage diseases |
title_full |
Bone mineral density in patients with hepatic glycogen storage diseases |
title_fullStr |
Bone mineral density in patients with hepatic glycogen storage diseases |
title_full_unstemmed |
Bone mineral density in patients with hepatic glycogen storage diseases |
title_sort |
Bone mineral density in patients with hepatic glycogen storage diseases |
author |
Jacoby, Jesica Tamara |
author_facet |
Jacoby, Jesica Tamara Santos, Bruna Bento dos Nalin, Tatiéle Colonetti, Karina Refosco, Lilia Farret Souza, Carolina Fischinger Moura de Spritzer, Poli Mara Poloni, Soraia Mendes, Roberta Hack Schwartz, Ida Vanessa Doederlein |
author_role |
author |
author2 |
Santos, Bruna Bento dos Nalin, Tatiéle Colonetti, Karina Refosco, Lilia Farret Souza, Carolina Fischinger Moura de Spritzer, Poli Mara Poloni, Soraia Mendes, Roberta Hack Schwartz, Ida Vanessa Doederlein |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Jacoby, Jesica Tamara Santos, Bruna Bento dos Nalin, Tatiéle Colonetti, Karina Refosco, Lilia Farret Souza, Carolina Fischinger Moura de Spritzer, Poli Mara Poloni, Soraia Mendes, Roberta Hack Schwartz, Ida Vanessa Doederlein |
dc.subject.por.fl_str_mv |
Densidade óssea Doença de depósito de glicogênio Osteocalcina |
topic |
Densidade óssea Doença de depósito de glicogênio Osteocalcina Glycogen storage disease Bone mineral density GSD Bone Osteocalcin Photon absorptiometry |
dc.subject.eng.fl_str_mv |
Glycogen storage disease Bone mineral density GSD Bone Osteocalcin Photon absorptiometry |
description |
The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9–20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, n = 18), procollagen type 1 N-terminal propeptide (P1NP, n = 19), collagen type 1 C-terminal telopeptide (CTX, n = 18) and 25-OH Vitamin D (n = 23) were also measured. The participants completed a 3-day food diary (n = 20). Low BMD was defined as a Z-score ≤ −2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ −2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential. |
publishDate |
2021 |
dc.date.accessioned.fl_str_mv |
2021-12-07T04:31:02Z |
dc.date.issued.fl_str_mv |
2021 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/232609 |
dc.identifier.issn.pt_BR.fl_str_mv |
2072-6643 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001134120 |
identifier_str_mv |
2072-6643 001134120 |
url |
http://hdl.handle.net/10183/232609 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Nutrients. Basel. Vol. 13, no. 9 (Sept. 2021), 2987, 11 p. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/232609/2/001134120.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/232609/1/001134120.pdf |
bitstream.checksum.fl_str_mv |
8e66b50a82eea290aa33a3b7ddbeb464 2fde56dd495550fbb1bcb7f2b43677b6 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1801225044940029952 |